Globally recognized leader in early-phase oncology clinical development and experimental therapeuticsStrengthens strategic ...
The gut microbiome is no longer viewed as a mere spectator in cancer development – it is increasingly recognized as a key ...
Morning Overview on MSN
A nasal spray reversed signs of brain aging in early tests, and a patent is already filed
Researchers at Texas A&M University reported that two intranasal doses of extracellular vesicles derived from human neural ...
Cancer remains notoriously difficult to treat, partly because tumors co‑opt their surrounding environment, including the ...
MusicRadar on MSN
We meet the people using test equipment to make music
Curious about how to make music with raw oscillators and other pieces of exotic Cold War-era test equipment? Don your lab coat and find out how you can incorporate old gear into your own productions.
Researchers discovered that a potential drug developed at Michigan Medicine treats severe fatty liver disease by improving ...
14h
Breakthrough T1D Awards Grant to Support PRISE‑hATG Study of SAB‑142 in Stage 3 Type 1 Diabetes
Breakthrough T1D, the leading global type 1 diabetes (T1D) research and advocacy organization and SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing a ...
When Anthropic's interpretability team asked whether there might be concepts inside Claude that the model was actively entertaining without writing down, they built a mathematical tool to find out.
Potentially first-in-class oral TNIK inhibitor advances into late-stage development after milestones marked by vital ...
Breakthrough T1D, the leading global type 1 diabetes (T1D) research and advocacy organization and SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results